Pharmerit Announces Opening of Oxford UK Office

April 15, 2019 (York, UK) – Pharmerit International (Pharmerit), a leading provider of health economics and outcomes research (HEOR) and market access research services, has announced the opening of a new office in Oxford, UK. The Oxford team—including Elisabeth Fenwick, PhD, MSc, Senior Director, Modeling and Meta-Analysis, and James Eaton, MSc, Senior Director, Strategic Market Access—are excited to serve our sponsors from their new base in Oxford.

“We are excited to be opening this new space in Oxford to complement and build on the success of our York-based group. We look forward to enhancing our partnerships and reputation amongst pharma, biotech, and medical device companies in London and the South of England and expanding the Pharmerit footprint within the UK and globally. Our expanded presence in the UK will enable Pharmerit to meet the health economic and market access needs of clients and will provide a strong scientific and strategic presence to assist our clients in accelerating access to treatments, benefiting patients locally and globally,” says James.

Executive Director Stephanie Stephens says, “Elisabeth and James bring a wealth of experience in health economics and market access. Their multidimensional thinking supports smarter decisions and better outcomes for our clients. To open our second UK office in Oxford is exciting because it brings us closer to existing and new clients and enables us to connect with an extended recruitment pool of experienced and talented professionals. We are very happy with this addition to Pharmerit’s geographical presence and are enthusiastic about the opportunities it brings.”

DOWNLOAD PRESS RELEASE